Editor's note: "US Stock Gold Mining" Keep up with daily market trends, insight, and consolidate hot and outstanding stocks, providing multi-dimensional investment opportunities for Mooer and helping them grasp investment opportunities with one chart! Focus on: 1. Performance and stock prices take off! Global fast fashion giant $Gap Inc (GPS.US)$ soared nearly 29% after its performance, reaching a new high for the year. Gap announced its first fiscal 2023 first-quarter results, with net sales of $3.4 billion, exceeding analysts' expectations of $3.28 billion, and earnings per share of $0.41, with overall comparable sales growth of 3%, better than expected 0.91%. In addition, the gross profit margin for the quarter reached 41.2%, higher than analysts' forecast of 38.5%. Its subsidiary brand Old Navy's same-store sales grew by 3%, exceeding market expectations of 2.5%. Based on this, Gap raised its sales and operating profit outlook for the year. Baird has recently raised its target share price for Gap from $23 to $28, and Goldman Sachs has raised its target share price for Gap from $20 to $27. 2. US electric power stocks collectively agitated! The largest wind and solar power generator developer in the United States $NextEra Energy (NEE.US)$, the fourth largest power plant in the United States $Southern Company (SO.US)$, the power and natural gas company $CenterPoint Energy (CNP.US)$, and the electrical production and transmission company $Edison International (EIX.US)$ have all reached new highs for the year. On the news front, as AI technology often requires a lot of energy to develop and operate, utility stocks are becoming a new opportunity for investors. 3. Low-key AI beneficiaries! Data storage giantThis week's bullish stocks in Hong Kong and the US stock markets.This section closely follows market trends every week, reviews the weekly performance of the Hong Kong and US stock markets, and helps mooers sort out the hot sectors, strong individual stocks, and major news of the week, looking for investment themes with profit potential.
Hong Kong stocks experienced significant fluctuations due to the impact of external markets from Monday this week, but welcomed a wave of gains on the last trading day of the week, and worries about a recession in the United States gradually eased.
This week, the Hang Seng Index rose by 0.85%, reaching 17090.23 points; during the same period, the Hang Seng Tech Index rose by 1.51%, reaching 3436.8 points; the China Enterprises Index rose by 0.72% during the same period, reaching 6017.85 points.
In terms of specific individual stocks, the company is balanced in underwriting and investment, and the net profit is expected to grow by 150% to 200% in the first half of the year!$CHINA RE (01508.HK)$This week surged by nearly 27%.
China Reinsurance recently released a profit upgrade announcement. Based on preliminary calculations, net profit attributable to shareholders of its parent company for the six months ended June 30, 2024 is expected to increase by about 150% to 200% compared with the same period in 2023, which is about RMB 2.012 billion yuan.
$WHARF REIC (01997.HK)$Recorded a weekly increase of more than 17%, with slightly lower income in the first half of the year, but strong profitability continued! The potential interest rate cut in the United States will boost growth in the second half of the year; meanwhile,$SWIREPROPERTIES (01972.HK)$Announced mid-term performance and plans to conduct a maximum of HKD 1.5 billion share buyback plan, with a nearly 12% increase in half a day.
Wharf REIC's hotel and investment income in the first half of the year were slightly lower than expected. The company will benefit from the improvement of Hong Kong retail sales and the favorable factor of falling rent next year. The bank believes that despite the weak environment of Hong Kong retail sales and office leasing in the first half of the year, the company's basic net profit was still strong during the period, although the mid-term dividend payout was down 4% year-on-year, which is also lower than the bank's estimate of 6%. In addition, the mid-term investment property EBIT was in line with expectations.
Dahua Jicheng believes that, for the second half of this year, Wharf REIC is expected to be the main beneficiary of potential interest rate cuts in the United States. The report stated that the company's basic profits in the first half of the year increased by 2.1% year-on-year, benefiting from the rise in retail rental income and the decrease in financial costs. However, considering that Hong Kong's retail sales recovery is weaker than expected, Wharf REIC's basic profit forecast for 2024, 2025, and 2026 is reduced by 6.7%, 10.1%, and 9.2%, respectively.
The release of the new medical insurance catalog sends a positive signal, and institutions believe that the pharmaceutical sector has entered a golden opportunity!$HANSOH PHARMA (03692.HK)$Rose nearly 14% during the week. The listing of Ametinib has set off a wave of enthusiasm, and the future market growth potential is broad; $BEIGENE (06160.HK)$ Achieved five consecutive increases, rising more than 13% during the week; $GENSCRIPT BIO (01548.HK)$ Rose more than 12% during the week.
According to the work arrangement of adjusting the national basic medical insurance, work-related injury insurance, and maternity insurance drug list in 2024, the National Medical Insurance Bureau recently conducted a preliminary review of declared drugs and announced the drugs and information that have passed the review.
Industry experts have stated that with the gradual implementation of policies, the environment for innovative drugs, from financing to research and development to application and promotion, is expected to gradually improve. This will help companies to bring innovative drugs to the market earlier and provide more treatment options for patients. After passing the half-year report window, the pharmaceutical industry is expected to see overall year-on-year improvement and quarter-on-quarter growth in performance in the second half of the year.
On the other hand, the following stocks performed weakly this week:
Editor/Feynman
